Acne & Oily Skin on Androgens
The Sebaceous-Gland Mechanism and the Dose Relationship
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Recognized androgen-dependent dermatologic effect
Reference only. Not medical advice.
What can go wrong
Acne on androgens ranges from mild facial/truncal oiliness to severe, scarring nodulocystic and acne fulminans-type eruptions seen with high-dose AAS. It is dose-dependent and can be managed with standard dermatologic therapy (topical retinoids, benzoyl peroxide, oral antibiotics, and isotretinoin for severe disease), but persistence usually reflects ongoing androgen load. Scarring is permanent. The visible appearance of new severe acne in an adult man is a recognized clue to anabolic-steroid use.
This is something to take to a clinician. The Atlas can tell you what is known about acne & oily skin on androgens in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Acne and oily skin are among the most reliable androgenic effects of testosterone therapy, and they are dose-dependent. Sebaceous glands are androgen target organs: androgens (especially DHT generated locally) stimulate sebocyte proliferation and sebum output, which combines with follicular hyperkeratinization and Cutibacterium acnes to produce inflammatory acne. The effect is usually mild at replacement doses and prominent at supraphysiological ones.
The sebaceous gland is an androgen target organ; more androgen means more sebum.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
Sebocytes express androgen receptors and the enzymes to convert testosterone to the more potent DHT locally. Androgenic stimulation increases sebocyte proliferation and lipogenesis, raising sebum output. Excess sebum, abnormal keratinization of the follicular duct, colonization by Cutibacterium acnes, and the resulting inflammation produce comedones, papules, pustules, and in severe cases nodulocystic acne. Because the response scales with androgen exposure, acne severity tracks dose and is often an early, visible marker that a regimen is supraphysiological.
Safety in detail
- Sebaceous glands are androgen-responsive; DHT is the local driver
- Severity is dose-dependent and tracks supraphysiological use
- Truncal (chest/back) acne is a classic high-androgen pattern
- Severe nodulocystic acne can scar permanently
- New severe adult-onset acne is a clue to AAS use
Replacement is not the same as a cycle
Replacement-dose acne is usually mild and manageable. Supraphysiological AAS frequently cause severe, truncal, scarring acne and occasionally acne fulminans, reflecting the steep dose-response of sebaceous androgen stimulation.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Skin assessment at baseline and follow-up
- Dermatology referral for moderate-to-severe or scarring disease
What people get wrong
Often saidAcne on TRT means the body is detoxing
ActuallyAcne is a direct androgenic effect on sebaceous glands, not detoxification; it scales with dose and resolves with dose adjustment and dermatologic care.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Target organ
- Sebaceous gland (sebocytes)
- Local androgen
- DHT (via skin 5-alpha-reductase)
- Output
- Increased sebum production
- Typical sites
- Face, chest, shoulders, upper back
- Relationship
- Dose-dependent
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Acne & Oily Skin on Androgens. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Pochi & Strauss, sebaceous gland response to androgens1974
Demonstrated androgen control of human sebum production, establishing the sebaceous gland as an androgen target organ